K

kailera

Legal Tech

Kailera Therapeutics is a biotechnology company focused on developing next-generation injectable and oral therapies for chronic weight management. Founded in 2024, the company is headquartered in Waltham, Massachusetts, and has a team of 51-200 employees. Kailera has secured significant funding, including a $600 million Series B round in October 2025 and a $400 million Series A round in October 2024.